For example, our group has found resveratrol to be a potent complement to mTOR inhibitors in diseases affected by mTOR hyperactivation.22 While rapamycin has been shown to be a viable therapeutic agent in certain cancers, it is ineffective in monotherapy due to the regulatory feedback loop between mTOR and Akt. Here, MTOR is linked to cancer.